WO1998021343B1 - Genes codant des proteines de telomerase - Google Patents

Genes codant des proteines de telomerase

Info

Publication number
WO1998021343B1
WO1998021343B1 PCT/US1997/021248 US9721248W WO9821343B1 WO 1998021343 B1 WO1998021343 B1 WO 1998021343B1 US 9721248 W US9721248 W US 9721248W WO 9821343 B1 WO9821343 B1 WO 9821343B1
Authority
WO
WIPO (PCT)
Prior art keywords
seq
polypeptide
nucleic acid
acid molecule
vector
Prior art date
Application number
PCT/US1997/021248
Other languages
English (en)
Other versions
WO1998021343A8 (fr
WO1998021343A1 (fr
Filing date
Publication date
Priority claimed from US08/751,189 external-priority patent/US5919656A/en
Priority claimed from US08/951,733 external-priority patent/US7390891B1/en
Application filed filed Critical
Priority to JP52294198A priority Critical patent/JP2001527385A/ja
Priority to AU52644/98A priority patent/AU5264498A/en
Priority to EP97947600A priority patent/EP0939823A1/fr
Priority to CA002271718A priority patent/CA2271718A1/fr
Publication of WO1998021343A1 publication Critical patent/WO1998021343A1/fr
Publication of WO1998021343B1 publication Critical patent/WO1998021343B1/fr
Publication of WO1998021343A8 publication Critical patent/WO1998021343A8/fr

Links

Abstract

L'invention concerne des molécules d'acide nucléique, qui codent des polypeptides du complexe télomérase. L'invention se rapporte également à des procédés de préparation desdites molécules d'acide nucléique et desdits polypeptides et à des procédés d'utilisation desdites molécules.
PCT/US1997/021248 1996-11-15 1997-11-13 Genes codant des proteines de telomerase WO1998021343A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP52294198A JP2001527385A (ja) 1996-11-15 1997-11-13 テロメラーゼ蛋白質をコードする遺伝子
AU52644/98A AU5264498A (en) 1996-11-15 1997-11-13 Genes encoding telomerase proteins
EP97947600A EP0939823A1 (fr) 1996-11-15 1997-11-13 Genes codant des proteines de telomerase
CA002271718A CA2271718A1 (fr) 1996-11-15 1997-11-13 Genes codant des proteines de telomerase

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US08/751,189 1996-11-15
US08/751,189 US5919656A (en) 1996-11-15 1996-11-15 Genes encoding telomerase protein 1
US87303997A 1997-06-11 1997-06-11
US08/873,039 1997-10-16
US08/951,733 US7390891B1 (en) 1996-11-15 1997-10-16 Polynucleotides encoding a telomerase component TP2
US08/951,733 1997-10-16

Publications (3)

Publication Number Publication Date
WO1998021343A1 WO1998021343A1 (fr) 1998-05-22
WO1998021343B1 true WO1998021343B1 (fr) 1998-07-30
WO1998021343A8 WO1998021343A8 (fr) 2002-01-31

Family

ID=27419411

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/021248 WO1998021343A1 (fr) 1996-11-15 1997-11-13 Genes codant des proteines de telomerase

Country Status (5)

Country Link
US (1) US7390891B1 (fr)
EP (1) EP0939823A1 (fr)
AU (1) AU5264498A (fr)
CA (1) CA2271718A1 (fr)
WO (1) WO1998021343A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6808880B2 (en) 1996-10-01 2004-10-26 Geron Corporation Method for detecting polynucleotides encoding telomerase
US6093809A (en) 1996-10-01 2000-07-25 University Technology Corporation Telomerase
US7585622B1 (en) 1996-10-01 2009-09-08 Geron Corporation Increasing the proliferative capacity of cells using telomerase reverse transcriptase
US6261836B1 (en) 1996-10-01 2001-07-17 Geron Corporation Telomerase
US6777203B1 (en) 1997-11-19 2004-08-17 Geron Corporation Telomerase promoter driving expression of therapeutic gene sequences
US6475789B1 (en) 1996-10-01 2002-11-05 University Technology Corporation Human telomerase catalytic subunit: diagnostic and therapeutic methods
US6610839B1 (en) 1997-08-14 2003-08-26 Geron Corporation Promoter for telomerase reverse transcriptase
ATE245194T1 (de) * 1996-10-01 2003-08-15 Geron Corp Katalytische untereinheit der menschlichen telomerase
WO1998037181A2 (fr) * 1997-02-20 1998-08-27 Whitehead Institute For Biomedical Research Gene de sous-unite catalytique de telomerase et proteine codee
US7622549B2 (en) * 1997-04-18 2009-11-24 Geron Corporation Human telomerase reverse transcriptase polypeptides
US7413864B2 (en) 1997-04-18 2008-08-19 Geron Corporation Treating cancer using a telomerase vaccine
AU745420B2 (en) * 1997-06-20 2002-03-21 Bayer Aktiengesellschaft Human catalytic telomerase sub-unit and its diagnostic and therapeutic use
IL133830A0 (en) * 1997-07-01 2001-04-30 Cambia Biosystems Llc Vertebrate tolomerase genes and proteins and uses thereof
EP1571215A3 (fr) * 1997-07-01 2007-10-31 Cambia Biosystems LLC Gènes et protéines de télomérases de vertèbres et leurs utilisations
US7378244B2 (en) 1997-10-01 2008-05-27 Geron Corporation Telomerase promoters sequences for screening telomerase modulators
AU1606999A (en) * 1997-11-26 1999-06-15 Albert Einstein College Of Medicine Of Yeshiva University Mouse telomerase reverse transcriptase
US6337200B1 (en) 1998-03-31 2002-01-08 Geron Corporation Human telomerase catalytic subunit variants
JP2002509716A (ja) 1998-03-31 2002-04-02 ユニバーシティ テクノロジー コーポレイション テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物
US7402307B2 (en) 1998-03-31 2008-07-22 Geron Corporation Method for identifying and killing cancer cells
US7030211B1 (en) 1998-07-08 2006-04-18 Gemvax As Antigenic peptides derived from telomerase
US6995145B1 (en) 1999-06-04 2006-02-07 Au Jessie L-S Methods and compositions for modulating drug activity through telomere damage
US6492171B2 (en) 2000-05-16 2002-12-10 Isis Pharmaceuticals, Inc. Antisense modulation of TERT expression
US6331399B1 (en) 2000-05-16 2001-12-18 Isis Pharmaceuticals, Inc. Antisense inhibition of tert expression
AUPR769701A0 (en) * 2001-09-14 2001-10-11 Li, He Telomerase inhibitory peptides and uses thereof
US7294708B2 (en) * 2002-05-31 2007-11-13 Beijing Institute Of Biotechnology Telomerase reverse transcriptase fragments and uses thereof
ES2376010T3 (es) * 2006-10-12 2012-03-08 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.R.L. Prote�?na de fusión de transcriptasa inversa de la telomerasa, nucleótidos que la codifican y usos de la misma.
KR20130024888A (ko) 2010-02-16 2013-03-08 오슬로 유니버시티 하스피탈 에이치에프 폴리펩티드
JP6517692B2 (ja) * 2012-09-19 2019-05-22 ジェムバックス アンド カエル カンパニー，リミティド 細胞透過性ペプチド、それを含んだコンジュゲート、及びそれを含んだ組成物

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4263428A (en) 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
DE3169595D1 (en) 1980-11-10 1985-05-02 Gersonde Klaus Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
EP0088046B1 (fr) 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipides en phase aqueuse
US4452747A (en) 1982-03-22 1984-06-05 Klaus Gersonde Method of and arrangement for producing lipid vesicles
DE3218121A1 (de) 1982-05-14 1983-11-17 Leskovar, Peter, Dr.-Ing., 8000 München Arzneimittel zur tumorbehandlung
HUT35524A (en) 1983-08-02 1985-07-29 Hoechst Ag Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
EP0143949B1 (fr) 1983-11-01 1988-10-12 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Composition pharmaceutique contenant de l'urokinase
EP0154316B1 (fr) 1984-03-06 1989-09-13 Takeda Chemical Industries, Ltd. Lymphokine chimiquement modifiée et son procédé de préparation
ATE135370T1 (de) 1988-12-22 1996-03-15 Kirin Amgen Inc Chemisch modifizierte granulocytenkolonie erregender faktor
US5252714A (en) 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
US5639613A (en) 1992-05-13 1997-06-17 Board Of Regents, University Of Texas System Methods for cancer diagnosis and prognosis
US5489508A (en) 1992-05-13 1996-02-06 University Of Texas System Board Of Regents Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
US5648215A (en) 1992-05-13 1997-07-15 Board Of Regents, The University Of Texas System Telomerase diagnostic methods
US5645986A (en) 1992-05-13 1997-07-08 Board Of Reagents, The University Of Texas System Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
US5629154A (en) 1993-11-12 1997-05-13 Geron Corporation Telomerase activity assays
US5489743A (en) 1993-01-19 1996-02-06 Amgen Inc. Transgenic animal models for thrombocytopenia
JPH08509870A (ja) 1993-05-26 1996-10-22 オンタリオ キャンサー インスティテュート 特定のｃｄ４５イソ型タンパク質の発現を遮断するトランスジェニック哺乳動物
US6664107B1 (en) 1993-05-26 2003-12-16 Ontario Cancer Institute, University Health Network CD45 disrupted nucleic acid
WO1995013382A1 (fr) 1993-11-12 1995-05-18 Geron Corporation Diagnostic et traitement de desordres lies a la longueur de telomeres et/ou l'activite de la telomerase
US5972605A (en) 1994-07-07 1999-10-26 Geron Corporation Assays for regulators of mammalian telomerase expression
PL181019B1 (pl) 1994-07-07 2001-05-31 Geron Corp Składnik RNA ssaczej telomerazy i sposób wytwarzania rekombinowanego enzymu telomerazy
US5583016A (en) 1994-07-07 1996-12-10 Geron Corporation Mammalian telomerase
US5635349A (en) 1994-12-02 1997-06-03 Tularik, Inc. High-throughput screening assay for inhibitors of nucleic acid polymerases
WO1996019580A2 (fr) 1994-12-19 1996-06-27 Cold Spring Harbor Laboratory Fraction proteinique de la telomerase
US6054442A (en) 1995-07-06 2000-04-25 Board Of Regents, University Of Texas System Methods and compositions for modulation and inhibition of telomerase in vitro
WO1997035967A2 (fr) 1996-03-28 1997-10-02 Cold Spring Harbor Laboratory Organismes transgeniques presentant une alteration de l'activite de la telomerase
WO1997037691A1 (fr) 1996-04-10 1997-10-16 Lynx Therapeutics, Inc. Inhibiteurs de la telomerase
US5770422A (en) 1996-07-08 1998-06-23 The Regents Of The University Of California Human telomerase
US5747317A (en) 1996-07-08 1998-05-05 Tularik Inc. Human telomerase RNA interacting protein gene
AU3798997A (en) 1996-07-17 1998-02-09 David E. Burstein Telomerase assay for precancerous lesions of the uterine cervix
JPH1028600A (ja) 1996-07-17 1998-02-03 Kyowa Hakko Kogyo Co Ltd テロメラーゼ活性の測定法
WO1998007838A1 (fr) 1996-08-21 1998-02-26 Mitsubishi Chemical Corporation Proteine de telomerase d'animaux superieurs et gene codant pour elle
WO1998008938A1 (fr) 1996-08-28 1998-03-05 Shonen Yoshida Proteines ayant une activite de telomerase
JP2001500379A (ja) 1996-09-13 2001-01-16 ジェロン コーポレイション テロメア長およびテロメア活性を調節するための方法および試薬
US6475789B1 (en) * 1996-10-01 2002-11-05 University Technology Corporation Human telomerase catalytic subunit: diagnostic and therapeutic methods
US6093809A (en) * 1996-10-01 2000-07-25 University Technology Corporation Telomerase
ATE245194T1 (de) 1996-10-01 2003-08-15 Geron Corp Katalytische untereinheit der menschlichen telomerase
US6261836B1 (en) * 1996-10-01 2001-07-17 Geron Corporation Telomerase
US6337200B1 (en) * 1998-03-31 2002-01-08 Geron Corporation Human telomerase catalytic subunit variants

Similar Documents

Publication Publication Date Title
WO1998021343B1 (fr) Genes codant des proteines de telomerase
CA2087261A1 (fr) Clonage de peptides dans un but de purification
JP4189035B2 (ja) 溶解性を向上させた組換えヒトインターフェロン−β
KR960704038A (ko) 세포 표면 수용체 Hek와 결합하는 사이토킨(Cytokines That Bind the Cell Surface Receptor Hek)
WO1998056927A3 (fr) Acides nucleiques codant des polypeptides a fonction protease
EP0889133A3 (fr) Procédé de préparation de transglutaminase microbienne
CA2249233A1 (fr) Codage des apotose proteases mch4 et mch5 par des acides nucleiques, et methodes d'utilisation
CA2180103A1 (fr) Gene codant par les adseverines
KR20110106286A (ko) 친화성 태그가 결합된 융합 콜라게나제 및 그의 제조방법
WO2006042719A3 (fr) Polypeptide presentant une activite de phytase et sequence nucleotidique codant ce polypeptide
CA2252493A1 (fr) Gene de la .beta.-galactoside - .alpha. 2,6-sialyltransferase
AU653526B2 (en) Novel signal sequences
EP0857789A3 (fr) Acide férulique décarboxylase
WO2000000607B1 (fr) Acide nucleique codant pour une proteine de liaison du retinoblastome (rbp-7) et marqueurs polymorphes associes a cet acide nucleique
AU8649698A (en) Cell cycle-regulating proteins
US7771970B2 (en) Process for preparation of polypeptides of interest from fusion polypeptides
CA2241786A1 (fr) Nouvelles proteines kinases activees par l'amp
CA2384122A1 (fr) Synthases de depsipeptides cycliques, genes correspondants et systeme de production de masse de ces depsipeptides cycliques
CA2253006A1 (fr) Gene hydroxylase de beta-carotene
WO2002010384A1 (fr) Genes codant des proteines capables de regenerer la luciferine, adn recombine et methode de production de proteines capables de regenerer la luciferine
WO1999054436A3 (fr) Acides nucleiques et proteines de genes de type insuline derives de c. elegans, et leurs utilisations
KR920000932A (ko) 효소 및 이를 암호화하는 dna
CA2374513A1 (fr) Adn et polypeptides il-1 eta
CA2348732A1 (fr) Proteines humaines h37 et adnc les codant
Zhao et al. Ruminant brain ribonucleases: expression and evolution